That's not quite right here
Authors perspective and future directions Current evidence supports SGLT2 inhibitors as a core component of contemporary heart failure management because of their consistent reductions in HF hospitalization and cardiovascular death across a broad range of patient populations [8,9,10,11,12,13, 45, 49]

If adverse drug reactions occur, contact your healthcare professional, pharmacist, or directly to the information database on adverse drug reactions (actions), including reports of drug ineffectiveness RSE on REM "National Center for Expertise of Medicines and Medical Devices" of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan additional information Composition of the medicinal product One bottle contains: active substance: reduced glutathione sodium salt - 0.646 g, corresponds to 600 mg reduced glutathione one ampoule with solvent contains: water for injection Release form and packaging 0.646 g of the drug is placed in a transparent glass bottle, sealed with a rubber stopper and sealed with an aluminum cap
Concurrent medications with cardiovascular contraindications identified during consult
The medication continues working to maintain that new set point, which is why discontinuation often leads to weight regain